Search alternatives:
step decrease » sizes decrease (Expand Search), teer decrease (Expand Search)
we decrease » _ decrease (Expand Search), mean decrease (Expand Search), teer decrease (Expand Search)
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a step » _ step (Expand Search)
step decrease » sizes decrease (Expand Search), teer decrease (Expand Search)
we decrease » _ decrease (Expand Search), mean decrease (Expand Search), teer decrease (Expand Search)
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a step » _ step (Expand Search)
-
11501
Image_9_Mouse models of lung-specific SARS-CoV-2 infection with moderate pathological traits.pdf
Published 2022“…After inoculation of 10<sup>5</sup> PFU of SARS-CoV-2 to the K18-hACE2, SFTPB-hACE2, and SCGB1A1-hACE2 models, the peak viral titer was detected at 2 days post-infection and then gradually decreased. …”
-
11502
Image_7_Mouse models of lung-specific SARS-CoV-2 infection with moderate pathological traits.pdf
Published 2022“…After inoculation of 10<sup>5</sup> PFU of SARS-CoV-2 to the K18-hACE2, SFTPB-hACE2, and SCGB1A1-hACE2 models, the peak viral titer was detected at 2 days post-infection and then gradually decreased. …”
-
11503
Image_1_Mouse models of lung-specific SARS-CoV-2 infection with moderate pathological traits.pdf
Published 2022“…After inoculation of 10<sup>5</sup> PFU of SARS-CoV-2 to the K18-hACE2, SFTPB-hACE2, and SCGB1A1-hACE2 models, the peak viral titer was detected at 2 days post-infection and then gradually decreased. …”
-
11504
Image_6_Mouse models of lung-specific SARS-CoV-2 infection with moderate pathological traits.pdf
Published 2022“…After inoculation of 10<sup>5</sup> PFU of SARS-CoV-2 to the K18-hACE2, SFTPB-hACE2, and SCGB1A1-hACE2 models, the peak viral titer was detected at 2 days post-infection and then gradually decreased. …”
-
11505
Image_3_Mouse models of lung-specific SARS-CoV-2 infection with moderate pathological traits.pdf
Published 2022“…After inoculation of 10<sup>5</sup> PFU of SARS-CoV-2 to the K18-hACE2, SFTPB-hACE2, and SCGB1A1-hACE2 models, the peak viral titer was detected at 2 days post-infection and then gradually decreased. …”
-
11506
Image_2_Mouse models of lung-specific SARS-CoV-2 infection with moderate pathological traits.pdf
Published 2022“…After inoculation of 10<sup>5</sup> PFU of SARS-CoV-2 to the K18-hACE2, SFTPB-hACE2, and SCGB1A1-hACE2 models, the peak viral titer was detected at 2 days post-infection and then gradually decreased. …”
-
11507
Image_1_Mouse models of lung-specific SARS-CoV-2 infection with moderate pathological traits.pdf
Published 2022“…After inoculation of 10<sup>5</sup> PFU of SARS-CoV-2 to the K18-hACE2, SFTPB-hACE2, and SCGB1A1-hACE2 models, the peak viral titer was detected at 2 days post-infection and then gradually decreased. …”
-
11508
Image_6_Mouse models of lung-specific SARS-CoV-2 infection with moderate pathological traits.pdf
Published 2022“…After inoculation of 10<sup>5</sup> PFU of SARS-CoV-2 to the K18-hACE2, SFTPB-hACE2, and SCGB1A1-hACE2 models, the peak viral titer was detected at 2 days post-infection and then gradually decreased. …”
-
11509
Image_4_Mouse models of lung-specific SARS-CoV-2 infection with moderate pathological traits.pdf
Published 2022“…After inoculation of 10<sup>5</sup> PFU of SARS-CoV-2 to the K18-hACE2, SFTPB-hACE2, and SCGB1A1-hACE2 models, the peak viral titer was detected at 2 days post-infection and then gradually decreased. …”
-
11510
Image_4_Mouse models of lung-specific SARS-CoV-2 infection with moderate pathological traits.pdf
Published 2022“…After inoculation of 10<sup>5</sup> PFU of SARS-CoV-2 to the K18-hACE2, SFTPB-hACE2, and SCGB1A1-hACE2 models, the peak viral titer was detected at 2 days post-infection and then gradually decreased. …”
-
11511
Image_8_Mouse models of lung-specific SARS-CoV-2 infection with moderate pathological traits.pdf
Published 2022“…After inoculation of 10<sup>5</sup> PFU of SARS-CoV-2 to the K18-hACE2, SFTPB-hACE2, and SCGB1A1-hACE2 models, the peak viral titer was detected at 2 days post-infection and then gradually decreased. …”
-
11512
Image_2_Mouse models of lung-specific SARS-CoV-2 infection with moderate pathological traits.pdf
Published 2022“…After inoculation of 10<sup>5</sup> PFU of SARS-CoV-2 to the K18-hACE2, SFTPB-hACE2, and SCGB1A1-hACE2 models, the peak viral titer was detected at 2 days post-infection and then gradually decreased. …”
-
11513
Image_9_Mouse models of lung-specific SARS-CoV-2 infection with moderate pathological traits.pdf
Published 2022“…After inoculation of 10<sup>5</sup> PFU of SARS-CoV-2 to the K18-hACE2, SFTPB-hACE2, and SCGB1A1-hACE2 models, the peak viral titer was detected at 2 days post-infection and then gradually decreased. …”
-
11514
Molecular Dynamics with Chemical AccuracyAlkane Adsorption in Acidic Zeolites
Published 2023“…They show that the observed decrease of experimental apparent barriers from propane to pentane for alkane cracking in MFI (28 kJ mol<sup>–1</sup>) is largely due to increasing adsorption strengths (21 kJ mol<sup>–1</sup>) and to a much smaller extent to decreasing intrinsic barriers (7 kJ mol<sup>–1</sup>).…”
-
11515
Single-Molecule Magnets: Structural Characterization, Magnetic Properties, and <sup>19</sup>F NMR Spectroscopy of a Mn<sub>12</sub> Family Spanning Three Oxidation Levels
Published 2005“…Hysteresis loops obtained from single-crystal magnetization vs DC field scans are typical of single-molecule magnets with the coercivities increasing with decreasing <i>T</i> and increasing field sweep rate and containing steps caused by the quantum tunneling of magnetization (QTM). …”
-
11516
Design, Synthesis, and Biological Evaluation of New Peripheral 5HT<sub>2A</sub> Antagonists for Nonalcoholic Fatty Liver Disease
Published 2020“…Here, structural modifications of pimavanserin (CNS drug), a 5HT<sub>2A</sub> antagonist approved for Parkinson’s disease, led us to synthesize new peripherally acting 5HT<sub>2A</sub> antagonists. …”
-
11517
-
11518
-
11519
<i>Eh</i> promotes global neddylation of host cell proteins during <i>Eh</i>-macrophage contact.
Published 2021Subjects: -
11520